Bryan III, Miles R.
Tian, Xu
Tseng, Jui-Heng
Evangelista, Baggio A.
Ragusa, Joey V.
Bryan, Audra F.
Trotman, Winifred
Irwin, David
Cohen, Todd J.
Funding for this research was provided by:
National Institutes of Health (F32AG072826)
National Institutes of Health (P30AG072958)
National Institutes of Health (P01-AG-066597)
National Institutes of Health (RF1AG068063)
Alzheimer's Association (AARG-22-924321)
CurePSP (656-2018-06)
Article History
Received: 4 September 2024
Accepted: 22 September 2024
First Online: 12 October 2024
Declarations
:
: Not applicable.
: Not applicable.
: TJC and MRB are inventors of the ac-tau monoclonal antibodies described in this study, own the copyright, and could receive royalties. These relationships have been disclosed and are under management by UNC-Chapel Hill.